Course curriculum

    1. Diabetes Update and Medicine Optimisation

    2. Lecture Notes

    1. CPD Entry for Pharmacist

    2. CPD entry for GPs

    3. CPD Entry for Nurses

About this course

  • £14.99
  • 5 lessons
  • 1.5 hours of video content

Learning Points

By the end of this session, learners will be able to:

  • Review key updates from NICE guideline NG28 for type 2 diabetes management, including changes to treatment pathways and therapeutic options.

  • Identify key components of a structured diabetes review that can be delivered efficiently within a 10–15 minute consultation.

  • Apply current guideline updates and evidence-based approaches to optimise glycaemic control and cardiovascular risk management.

  • Recognise opportunities to optimise diabetes treatment pathways, including the appropriate use of modern therapies.

  • Identify clinical red flags, complications, and situations requiring escalation or referral to specialist services.

  • Improve confidence in delivering focused diabetes reviews that support improved patient outcomes within primary care.

Dr Mohamad Elnaggar

MD, MSc, PhD, MRCP London, MRCP Endo Endocrinologist/Diabetologist SCOPE certified for Obesity Management. Acute Medicine Consultant

Dr Mohamed Elnaggar is a General Practitioner with a specialist interest in diabetes and cardiometabolic medicine. He has extensive experience in the management of complex diabetes within primary care and PCN settings, with a particular focus on improving outcomes through evidence-based treatment optimisation and structured clinical reviews. Dr Elnaggar is actively involved in education and training for healthcare professionals, supporting clinicians across primary care to implement current NICE guidance and modern diabetes therapies safely and effectively. His teaching focuses on translating clinical guidelines into practical approaches that can be applied within time-limited consultations in everyday practice. He regularly delivers educational sessions on diabetes management, cardiovascular risk reduction, and treatment pathway optimisation, helping clinicians improve confidence in managing patients with type 2 diabetes in both community and primary care settings.

Master the Diabetes Review

Access NOW